This randomized trial studies how well acupressure works in decreasing treatment-related symptoms in childhood cancer patients. Acupressure may reduce treatment-related symptoms and help patients feel better.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03313193.
PRIMARY OBJECTIVES:
I. To assess the feasibility of an acupressure intervention plus usual care and to assess the benefits and risks compared to usual care alone for children receiving hospital-based treatment for a childhood cancer or hematopoietic stem cell transplant (HSCT).
II. To assess the benefits and challenges of providing the acupressure intervention for parents.
ADDITIONAL QUALITY OBJECTIVES:
I. To explore the child’s experience of receiving acupressure and the caregiver’s experience of delivering acupressure to the child through a semi-structured interview with the caregiver, with a focus on well-being.
II. To explore the acupressure provider’s impression of how provider- or caregiver-delivered acupressure impacts the child’s experience of childhood cancer treatment or HSCT.
OUTLINE: Patients are randomized into 1 of 2 arms.
ARM A: Patients receive ~20 acupressure treatments (avg 15-20 minutes each) 5-7 days per week over 1 month of continuous hospital-based treatment or over 2 months of intermittent hospital-based treatment and usual care for symptom management.
ARM B: Patients receive usual care for symptom management.
After completion of study, patients are followed up within 30 days.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUCSF Medical Center-Mount Zion
Principal InvestigatorAnne Lown